Immunocompromised adults or those who are older than 65 should get a second dose of the latest COVID-19 vaccine, the Centers ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

The Centers for Disease Control and Prevention provides funding for HIV prevention for the populations at the highest risk of ...

As the nation's AIDS walk marks its 40th year in Los Angeles, organizers say medical advances have taken lowered visibility ...

While annual HIV surveillance reports released by the CDC in May showed that the number of estimated new HIV infections per ...

The study examined the acceptability and feasibility of an integrated multicomponent strategy to enhance daily oral HIV pre-exposure prophylaxis (PrEP) uptake and adherence among transgender women ...

ViiV Healthcare sponsored events to address the climbing rates of HIV infections on HBCU campuses and the surrounding Black ...

Now more than 40 years since the discovery of the HIV pandemic. 8 The results of this study provide reason for optimism that offering long-acting antiretroviral options for PrEP, as part of a flexible ...

Five grantees, all in the South, will receive about $2 million each in federal funding for PrEP programs to prevent HIV.

More encouraging news has been announced about the new, twice-yearly PrEP injection currently undergoing trials. Lenacapavir is already in use as a treatment for HIV. However, pharma giant Gilead ...